GKB Ophthalmics

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE265D01015
  • NSEID: GKB
  • BSEID: 533212
INR
64.00
-1.54 (-2.35%)
BSENSE

Aug 31, 03:59 PM

BSE+NSE Vol: 1.91 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
GKB Ophthalmics
Centenial Surgic
Bandaram Pharma
Deccan Healthcar
N G Industries
Tejnaksh Health.
Chennai Meena
Adeshwar Meditex
Samsrita Labs
Sunrest Lifescie
Galaxy Medicare

Why is GKB Ophthalmics Ltd ?

1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 1.54%
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.30
2
The company has declared Positive results for the last 4 consecutive quarters
  • PAT(Latest six months) At Rs 2.69 cr has Grown at 158.86%
  • NET SALES(9M) At Rs 119.62 cr has Grown at 34.21%
  • ROCE(HY) Highest at 11.76%
3
With ROCE of 9, it has a Very Attractive valuation with a 0.7 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of NA, its profits have risen by 164.3% ; the PEG ratio of the company is 0
4
Majority shareholders : Promoters
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to GKB Ophthalmics should be less than 10%
  2. Overall Portfolio exposure to Healthcare Services should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
18.20%
EBIT Growth (5y)
46.47%
EBIT to Interest (avg)
0.30
Debt to EBITDA (avg)
5.54
Net Debt to Equity (avg)
0.13
Sales to Capital Employed (avg)
1.33
Tax Ratio
3.50%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.79%
ROCE (avg)
-0.62%
ROE (avg)
1.54%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
7
Industry P/E
81
Price to Book Value
0.63
EV to EBIT
5.47
EV to EBITDA
3.78
EV to Capital Employed
0.67
EV to Sales
0.27
PEG Ratio
0.04
Dividend Yield
NA
ROCE (Latest)
9.03%
ROE (Latest)
5.68%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Bearish
Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
PAT(Latest six months)

At Rs 2.69 cr has Grown at 158.86%

NET SALES(9M)

At Rs 119.62 cr has Grown at 34.21%

ROCE(HY)

Highest at 11.76%

-3What is not working for the Company
NET SALES(Q)

At Rs 33.04 cr has Fallen at -11.3% (vs previous 4Q average

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 4.90 cr

Loading Valuation Snapshot...

Here's what is working for GKB Ophthalmics

Profit After Tax (PAT) - Latest six months
At Rs 2.69 cr has Grown at 158.86%
Year on Year (YoY)
MOJO Watch
PAT trend is very positive

PAT (Rs Cr)

Profit After Tax (PAT) - Latest six months
Higher at Rs 2.69 cr
than preceding 12 month period ended Jun 2026 of Rs -2.23 cr
MOJO Watch
In the half year the company has already crossed PAT of the previous twelve months

PAT (Rs Cr)

Here's what is not working for GKB Ophthalmics

Net Sales - Quarterly
At Rs 33.04 cr has Fallen at -11.3% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 37.27 Cr
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 4.90 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents